Axillary Hyperhidrosis
12
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Treatment Research
16 treatments under study, led by Miradry
Research Leaders
13 sponsors active, led by Botanix Pharmaceuticals
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
8.3%
1 terminated out of 12 trials
90.0%
+3.4% vs benchmark
25%
3 trials in Phase 3/4
56%
5 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 9 completed trials
Clinical Trials (12)
Comparison of the Clinical Efficacy and Adverse Reactions of Different Needling Patterns of High-frequency Microneedles in the Treatment of Axillary Odor
Miradry Treatment for Focal Axillary Hyperhidrosis
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis
miraDry Post Market Tumescent Anesthesia Study
Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)
Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis
Tx Axillary Hyperhidrosis 1210nm Diode Laser
Clinical Evaluation of the miraDry System in Subjects With Hyperhidrosis
Use of Oxybutynin to Treat Axillary Hyperhidrosis
VASER Treatment of Axillary Hyperhidrosis/Bromidrosis
Research Network
Common Treatments
- Miradry2
- Vehicle2
- Miradry System Treatment With Energy1
- Sofpironium Bromide Gel 151
- Vaser1
Active Sponsors
- Botanix Pharmaceuticals2
- Miramar Labs1
- Johns Hopkins University1
- First Affiliated Hospital Of Chongqing Medical University1
- Sound Surgical Technologies Llc1
Related Conditions
- Osmidrosis1
- Hyperhidrosis1